Low Bone Strength and Mass Associated With Increased Risk for Major Adverse Coronary Events in Older Men
In this study, researchers assess the connection between bone fragility and major adverse coronary events in older men.
Bone Health
GnRHa Treatment in Early Puberty Impacts Hip Bone Geometry
Gender-affirming hormone started in early puberty, but not later in puberty or adulthood, alters hip bone geometry in transgender individuals.
Subcutaneous Leuprolide Acetate Shows Promise for Treatment of CPP
Researchers demonstrate the gonadotropin-releasing hormone agonist implant’s ability to control precocious puberty.
Patients With Type 2 Diabetes Have Trabecular Bone Fragility Due to Alterations in Bone Structure and Composition
Patients with type 2 diabetes face up to a three-fold increased risk of hip fracture, despite adequate areal bone mineral density which may underestimate fracture risk in these patients.
Surgery Skipped for Most Older Adults With Primary Hyperparathyroidism
Despite more inclusive surgical guidelines and evidence that shows surgery can improve quality of life, the procedure is performed less often these days—especially in older patients.
FSH Levels in Older Postmenopausal Women Affect Bone and Body Composition
The objective of this study was to investigate the associations between endogenous FSH levels and BMD, BMA, and body composition in older adults, independent of estradiol and testosterone levels.
Risks After Denosumab Discontinuation Linked to Age and Prior Therapy
Researchers sought to identify potential vertebral fracture and bone loss risk factors after discontinuation of denosumab therapy and initiation of other therapy.
Comparing Free and Bioavailable vs Total 25(OH)D to Predict Bone Health
Researchers sought to investigate the impact of vitamin D-specific variables on indices of bone and mineral metabolism in older adults.
Delayed Denosumab Injections Associated With Increased Vertebral Fracture Risk
Researchers estimated risk for fracture among patients receiving denosumab with delayed subsequent doses vs those who received doses on time.
Endocrine Society Updates Postmenopausal Osteoporosis Management Guidelines to Include Romosozumab
The Endocrine Society has issued an update to the organization’s 2019 clinical practice guideline on pharmacologic management of osteoporosis to include romosozumab.
-
Loading...
-
Loading...
Next post in Bone Metabolism
